Barclays PLC Alector, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Alector, Inc. stock. As of the latest transaction made, Barclays PLC holds 176,800 shares of ALEC stock, worth $339,456. This represents 0.0% of its overall portfolio holdings.

Number of Shares

176,800

Previous 176,800 -0.0%

Holding current value

$339,456

Previous $824,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$4.34 - $6.58 $437,172 - $662,809	100,731 Added 132.42%	176,800 $824,000
Q2 2024 Aug 14, 2024	SELL	$4.19 - $6.23 $109,593 - $162,951	-26,156 Reduced 25.59%	76,069 $346,000
Q1 2024 May 15, 2024	SELL	$5.69 - $8.08 $517,807 - $735,304	-91,003 Reduced 47.1%	102,225 $615,000
Q4 2023 Feb 15, 2024	BUY	$3.77 - $8.39 $205,095 - $456,432	54,402 Added 39.19%	193,228 $1.54 Million
Q3 2023 Nov 07, 2023	BUY	$5.2 - $8.77 $139,651 - $235,527	26,856 Added 23.98%	138,826 $899,000
Q2 2023 Aug 03, 2023	SELL	$5.86 - $7.93 $89,804 - $121,527	-15,325 Reduced 12.04%	111,970 $673,000
Q1 2023 May 04, 2023	SELL	$5.85 - $9.84 $66,959 - $112,628	-11,446 Reduced 8.25%	127,295 $789,000
Q4 2022 Feb 13, 2023	SELL	$6.88 - $9.55 $122,924 - $170,629	-17,867 Reduced 11.41%	138,741 $1.28 Million
Q3 2022 Nov 03, 2022	BUY	$8.19 - $13.2 $1.12 Million - $1.81 Million	137,308 Added 711.44%	156,608 $1.48 Million
Q2 2022 Aug 12, 2022	BUY	$7.65 - $14.24 $5,638 - $10,494	737 Added 3.97%	19,300 $196,000
Q1 2022 May 16, 2022	SELL	$13.02 - $20.78 $1.19 Million - $1.9 Million	-91,358 Reduced 83.11%	18,563 $265,000
Q4 2021 Feb 14, 2022	BUY	$19.35 - $25.54 $706,778 - $932,874	36,526 Added 49.77%	109,921 $2.27 Million
Q3 2021 Nov 09, 2021	BUY	$21.65 - $39.49 $350,340 - $639,027	16,182 Added 28.28%	73,395 $1.68 Million
Q2 2021 Aug 13, 2021	SELL	$15.5 - $22.48 $665,058 - $964,549	-42,907 Reduced 42.86%	57,213 $1.19 Million
Q1 2021 May 13, 2021	BUY	$14.84 - $22.23 $1 Million - $1.5 Million	67,520 Added 207.12%	100,120 $2.02 Million
Q4 2020 Feb 11, 2021	SELL	$9.4 - $16.7 $65,471 - $116,315	-6,965 Reduced 17.6%	32,600 $493,000
Q3 2020 Nov 12, 2020	SELL	$10.54 - $24.96 $287,963 - $681,932	-27,321 Reduced 40.85%	39,565 $417,000
Q2 2020 Aug 12, 2020	BUY	$21.87 - $33.11 $477,290 - $722,592	21,824 Added 48.43%	66,886 $1.63 Million
Q1 2020 May 13, 2020	SELL	$16.25 - $35.28 $65,016 - $141,155	-4,001 Reduced 8.15%	45,062 $1.09 Million
Q4 2019 Feb 10, 2020	BUY	$14.17 - $20.3 $332,513 - $476,359	23,466 Added 91.67%	49,063 $846,000
Q3 2019 Nov 14, 2019	BUY	$14.42 - $22.2 $164,835 - $253,768	11,431 Added 80.69%	25,597 $369,000
Q2 2019 Aug 14, 2019	BUY	$16.26 - $26.42 $204,810 - $332,786	12,596 Added 802.29%	14,166 $269,000
Q1 2019 May 15, 2019	BUY	$15.97 - $22.5 $25,072 - $35,325	1,570 New	1,570 $29,000

Others Institutions Holding ALEC

# of Institutions

168

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account